121.43

0.21% 0.25

Pre-market: 121.11 -0.32 -0.26%

Jazz Pharmaceuticals Plc (JAZZ)

Overview News Price History Option Chain Financials Discussions Forecast

Jazz Pharmaceuticals Plc stock is traded at $121.43, with a volume of 518.02K. It is up +0.21% in the last 24 hours and down -1.25% over the past month. Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Previous Close:

$121.18

Open:

$121.47

24h Volume:

518.02K

Relative Volume:

0.88

Market Cap:

$7.34B

Revenue:

$3.99B

Net Income/Loss:

$463.16M

P/E Ratio:

17.10

EPS:

7.1

Net Cash Flow:

$1.10B

1W Performance:

-1.24%

1M Performance:

-1.25%

6M Performance:

+11.39%

1Y Performance:

+4.20%

1-Day Range:

$120.06

$122.38

1-Week Range:

$120.06

$124.66

52-Week Range:

$99.06

$134.17

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name

Jazz Pharmaceuticals Plc

Sector

Healthcare (1176)

Industry

Biotechnology (685)

Phone

353-1-634-7800

Address

FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN

Employee

2,800

Twitter

@jazzpharma

Next Earnings Date

2024-11-06

Latest SEC Filings

JAZZ's Discussions on Twitter

Compare JAZZ with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
JAZZ Jazz Pharmaceuticals Plc	121.43	7.34B	3.99B	463.16M	1.10B	7.10
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-12-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-05-24	Initiated	Goldman	Buy
Jan-03-24	Initiated	Robert W. Baird	Outperform
Nov-27-23	Downgrade	UBS	Buy → Neutral
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight
Dec-09-22	Upgrade	Goldman	Neutral → Buy
Jun-14-22	Initiated	UBS	Buy
Apr-06-22	Downgrade	Goldman	Buy → Neutral
Nov-19-21	Resumed	Goldman	Buy
Oct-07-21	Resumed	Jefferies	Buy
Oct-05-21	Initiated	Citigroup	Buy
Sep-23-21	Initiated	Needham	Buy
May-19-21	Resumed	JP Morgan	Overweight
Apr-07-21	Resumed	RBC Capital Mkts	Outperform
Feb-05-21	Reiterated	H.C. Wainwright	Buy
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight
Jan-29-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-16-20	Initiated	UBS	Buy
Nov-03-20	Reiterated	H.C. Wainwright	Buy
Oct-09-20	Reiterated	H.C. Wainwright	Buy
Sep-14-20	Downgrade	Goldman	Neutral → Sell
Sep-14-20	Resumed	JP Morgan	Overweight
Aug-06-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jul-28-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Jul-23-20	Upgrade	H.C. Wainwright	Neutral → Buy
Apr-06-20	Initiated	Jefferies	Buy
Mar-12-20	Upgrade	Bernstein	Mkt Perform → Outperform
Jan-08-20	Initiated	Goldman	Neutral
Aug-21-19	Downgrade	Piper Jaffray	Overweight → Neutral
Jun-11-19	Initiated	Barclays	Overweight
Mar-20-19	Initiated	SunTrust	Buy
Dec-14-18	Initiated	Wolfe Research	Peer Perform
Nov-08-18	Reiterated	B. Riley FBR	Buy
Aug-08-18	Reiterated	Stifel	Buy
Jul-11-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-23-18	Reiterated	H.C. Wainwright	Neutral
Mar-19-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight

View All

Jazz Pharmaceuticals Plc Stock (JAZZ) Latest News

Jan 21, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Perpetual Ltd - MarketBeat

Jan 21, 2025

45,463 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by Lmcg Investments LLC - MarketBeat

Jan 21, 2025

MassMutual Private Wealth & Trust FSB Acquires 17,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 21, 2025

2,442 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Acquired by Aaron Wealth Advisors LLC - MarketBeat

Jan 21, 2025

5,811 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by Arkadios Wealth Advisors - MarketBeat

Jan 21, 2025

Jan 19, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Short Interest Update - MarketBeat

Jan 19, 2025

Kera Capital Partners Inc. Invests $288,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 19, 2025

Jan 18, 2025

Wedge Capital Management L L P NC Sells 48,679 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 18, 2025

Jan 17, 2025

Empirical Asset Management LLC Invests $5.36 Million in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 17, 2025

Jan 16, 2025

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Acquired by Hennion & Walsh Asset Management Inc. - MarketBeat

Jan 16, 2025

Burney Co. Grows Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Jan 16, 2025

Jan 15, 2025

JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline - MSN

Jan 15, 2025

14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey

Jan 15, 2025

JAZZ (Jazz Pharmaceuticals) Growth Rank : 7 (As of Jan. 15, 2025) - GuruFocus.com

Jan 15, 2025